Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases von Gutierrez-Cuevas, Jorge, Santos, Arturo, Armendariz-Borunda, Juan

Volltext

The Role of NRF2 in Obesity-Associated Cardiovascular Risk Factors von Gutiérrez-Cuevas, Jorge, Galicia-Moreno, Marina, Monroy-Ramírez, Hugo Christian, Sandoval-Rodriguez, Ana, García-Bañuelos, Jesús, Santos, Arturo, Armendariz-Borunda, Juan

Volltext

Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies von Gutiérrez-Cuevas, Jorge, Lucano-Landeros, Silvia, López-Cifuentes, Daniel, Santos, Arturo, Armendariz-Borunda, Juan

Volltext

The Methylenetetrahydrofolate Reductase C677T (rs1801133) and Apolipoprotein A5-1131T>C (rs662799) Polymorphisms, and Anemia Are Independent Risk Factors for Ischemic Stroke von Escobedo, Jorge, Paz–Aragón, Emmanuel, Vega–Rodríguez, Luz Helena, Benítez Sanfeliz, Miguel Alejandro, Estrada–Rodríguez, Humberto, González–Figueroa, Evangelina, Liceaga–Craviotto, María Gabriela, Gutiérrez–Cuevas, Jorge, Valladares–Salgado, Adán, Cruz, Miguel

Volltext

Pirfenidone decreases insulin, glucagon, leptin, plasminogen activator inhibitor 1, preventing nonalcoholic steatohepatitis and myocarditis in an obesity moldel von López-Cifuentes, Daniel, Gutiérrez-Cuevas, Jorge, Sandoval-Rodríguez, Ana S., Vázquez-Esqueda, Ángel O., Rodríguez-Sanabria, Jonathan S., Armendáriz-Borunda, Juan

Volltext

Roles of Nrf2 in Liver Diseases: Molecular, Pharmacological, and Epigenetic Aspects von Galicia-Moreno, Marina, Lucano-Landeros, Silvia, Monroy-Ramirez, Hugo Christian, Silva-Gomez, Jorge, Gutierrez-Cuevas, Jorge, Santos, Arturo, Armendariz-Borunda, Juan

Volltext

PHARMACEUTICAL USE OF PIRFENIDONE FOR REDUCING CARDIAC FIBROSIS IN PATIENTS WITH CARDIOMYOPATHY, CARDIAC STEATOSIS, AND COVID-19 von SANDOVAL RODRÍGUEZ Ana Soledad, ARMENDÁRIZ BORUNDA Juan Socorro, SANTOS GARCÍA Arturo, GUTIÉRREZ CUEVAS Jorge

Volltext bestellen